海外の治験の状況「1」での検索結果
7748件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- ECULIZUMAB THERAPY IN PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
- Membranoproliferative glomerulonephritis;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Italy
- 2013-10-28
Not recruiting
- Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral Sclerosis
- Amyotrophic Lateral Sclerosis
- France
- 2013-10-08
Not recruiting
- Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate
- Amyotrophic Lateral Sclerosis;Amyotrophic Lateral Sclerosis;Amyotrophic Lateral Sclerosis;Amyotrophic Lateral Sclerosis
- Germany
- 2013-09-28
Not Recruiting
- Human low density lipoprotein-metabolism in silico: Modeling the change of lipid-composition in the lipoprotein particle
- healthy participants
- Germany
- 2013-08-12
Not Recruiting
- A Phase 1/2, Proof-of-Principle, Multi-Center, Open-Label, Single-Arm, Non-randomized Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine Consisting of Genetically Modified Allogeneic (Human) Tumor Cells for the Expression of IL-7, GM-CSF, CD80 and CD154, in Fixed Combination With a DNA-based Double Stem Loop Immunomodulator in Patients With Advanced Renal Cell Carcinoma (ASET Study)
- Stage IV Renal Cell Cancer;C64 - Malignant neoplasm of kidney, except renal pelvis
- Germany
- 2013-06-07
Not Recruiting
- MINeralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-Elevation Myocardial Infarction (STEMI)
- Cardiovascular disease MedDRA version: 14.1 Level: PT Classification code 10007649 Term: Cardiovascular disorder System Organ Class: 10007541 - Cardiac disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- United Kingdom
- 2013-06-06
Not Recruiting
- A study to compare the compatibility and safety of LY900014 with insulin lispro given by insulin pump in patients with type 1 diabetes
- Diabetes Mellitus, Type 1 MedDRA version: 20.0 Level: PT Classification code 10012601 Term: Diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
- Spain, United States
- 2017-11-15
Not recruiting
- Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
- Graves Ophthalmopathy;Graves Disease;Autoimmune Thyroiditis
- Italy
- 2018-03-30
Not Recruiting
- Exploratory Study of Genetic Factors Related to the Inhibitory Effect of Tolvaptan on Increased Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease
- Autosomal Dominant Polycystic Kidney Disease
- Europe, Japan, North America
- 2018-03-29
Not recruiting
- A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Patients With Advanced Malignancies
- Advanced Malignancies
- Spain
- 2008-03-31
Not Recruiting
- Granulocyte colony-stimulating factor (G-CSF) and liver regeneration in patients with alcoholic steatohepatitis
- Alcoholic steatohepatitis Nutritional, Metabolic, Endocrine alcoholic steatohepatitis
- Switzerland
- 2008-03-14
Not Recruiting
- A Phase II multi-centre, extension study to investigate the long term safety of ONO-2506PO in patients diagnosed with Amyotrophic Lateral Sclerosis (ALS).
- Amyotrophic Lateral Sclerosis (ALS) br>MedDRA version: 9.1 Level: LLT Classification code 10002026 Term: Amyotrophic lateral sclerosis
- Belgium, France, Germany, United Kingdom
- 2008-01-29
Not Recruiting
- DINAMICA VIRAL DEL VIH-1 EN SUJETOS QUE INICIAN TERAPIA CON RALTEGRAVIR (HIV-1 VIRAL DYNAMICS IN SUBJECTS INITIATING RALTEGRAVIR THERAPY)
- Pacientes con infección VIH-1 (HIV-1 infection) MedDRA version: 9.1 Level: LLT Classification code 10000807 Term: Acute HIV infection
- Spain
- 2008-01-29
Not Recruiting
- Long-term extension of the multinational, double-blind, placebo controlled study PDY6045 and PDY6046 to document the safety of teriflunomide when added to treatment with interferon-beta or glatiramer acetate in patients with multiple sclerosis with relapses
- Multiple Sclerosis MedDRA version: 12.1 Level: LLT Classification code 10028245 Term: Multiple sclerosis
- Austria, Italy, Spain, United Kingdom
- 2007-08-20
Not Recruiting
- An open, randomised clinical Phase I/IIa trial to investigate the maximum tolerated dose, efficacy, safety and pharmacokinetics of repeated three-week courses of a single dose i.v. BI 2536 on day 1 in comparison to single doses i.v. BI 2536 on days 1, 2 and 3 in patients over 60 years of age with refractory or relapsed acute myeloid leukaemia
- Male or female patients older than 60 years of age with confirmed AML (except for APL) according to the WHO definition who relapsed after or are refractory to prior chemotherapy. Leukocyte count should be = 25,000 /µl (25 x 109/Liter). Patient should be not eligible for intensive treatment options. Patient should have a life expectancy = 2 months and Eastern co-operative oncology group performance score of 2 or less.
- Austria, Germany
- 2006-06-01
Not recruiting
- SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
- Familial Amyotrophic Lateral Sclerosis;Familial Amyotrophic Lateral Sclerosis;Familial Amyotrophic Lateral Sclerosis;Familial Amyotrophic Lateral Sclerosis
- Germany, Italy, Sweden, United States
- 2009-12-17
Not recruiting
- A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma
- Multiple Myeloma
- Belgium, Denmark, Sweden, United States
- 2009-12-01
Not Recruiting
- Aldosterone receptor blockade in patients with chronic kidney disease. Influence on arterial stiffness and kidney function. - ALBLOCK-2
- Chronic kidney disease, stages 3 and 4. MedDRA version: 9.1 Level: LLT Classification code 10064848 Term: Chronic kidney disease
- Denmark
- 2009-10-14
Not recruiting
- Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)
- Amyotrophic Lateral Sclerosis
- Belgium, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, United States
- 2009-09-22
Not Recruiting
- Phase I/II Trial of Valproic Acid and Carnitine in Infants with Spinal Muscular Atrophy Type I (CARNI-VAL Type I) - CARNI-VAL Type I
- Spinal Muscular Atrophy Type I in infants MedDRA version: 9.1 Level: LLT Classification code 10051203 Term: Spinal muscular atrophy congenital
- Germany
- 2009-06-25